Can Breztri (fluticasone propionate/umeclidinium/formoterol) be prescribed together with AirSupra (albuterol) for a patient?

Can Breztri and AirSupra Be Prescribed Together?

No, Breztri and AirSupra should not be prescribed together due to overlapping long-acting beta-agonist (LABA) components that create risk of beta-agonist overdose and duplication of therapy. 1, 2

Critical Safety Concerns

Medication Overlap and Contraindications

• Breztri contains formoterol fumarate (a LABA), while AirSupra contains albuterol (a short-acting beta-agonist, SABA) plus budesonide (an inhaled corticosteroid) 1, 2

• The FDA label for Breztri explicitly states: "Do not use other medicines that contain a LABA or an anticholinergic for any reason" and instructs patients to ask their healthcare provider if any of their other medicines contain LABA 1

• The FDA label for AirSupra warns: "Concomitant use of additional beta-agonists with AIRSUPRA should be used judiciously to prevent beta-agonist overdose" 2

Indication Mismatch

• Breztri is FDA-approved exclusively for COPD (chronic obstructive pulmonary disease) as maintenance therapy, containing budesonide/glycopyrrolate/formoterol 1

• AirSupra is FDA-approved exclusively for asthma in patients ≥18 years as anti-inflammatory reliever therapy, containing albuterol/budesonide 2, 3

• Breztri's label explicitly states: "BREZTRI AEROSPHERE is not for the treatment of asthma" 1

Appropriate Clinical Approach

For COPD Patients on Breztri

• Breztri already provides triple therapy (ICS/LAMA/LABA) for COPD maintenance treatment 1

• If rescue therapy is needed, prescribe albuterol alone (not AirSupra) as the rescue inhaler 1

• Breztri's label instructs: "Always have a rescue inhaler (an inhaled, short-acting bronchodilator) with you to treat sudden breathing problems" - this should be albuterol monotherapy 1

For Asthma Patients

• AirSupra serves as anti-inflammatory reliever therapy and can be used with or without maintenance ICS/LABA therapy 2, 3

• If a patient requires triple therapy-level treatment, they likely have COPD (not asthma alone), making AirSupra inappropriate 1, 2

For Asthma-COPD Overlap Syndrome (ACOS)

• Guidelines recommend ICS/LABA combinations for ACOS patients 4

• Choose either Breztri for COPD-predominant disease with albuterol rescue, OR maintenance ICS/LABA with AirSupra for asthma-predominant disease - but never both together 4

Common Pitfalls to Avoid

• Do not add AirSupra to Breztri thinking it provides "extra rescue therapy" - the beta-agonist duplication creates cardiovascular risk and potential for tachyphylaxis 2

• Do not confuse disease states: Breztri is COPD-only; AirSupra is asthma-only 1, 2

• Monitor for beta-agonist toxicity signs if inadvertent co-prescription occurs: tachycardia, tremor, hypokalemia, hyperglycemia 2

• The combination would also result in duplicative ICS exposure (both contain budesonide), increasing pneumonia risk without additional benefit 1, 2